Jens Lagergren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jens Lagergren has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
- Lars Arvestad
Stockholm University
8 shared publications - Johan Hartman
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
7 shared publications - Xinsong Chen
Karolinska Institutet
7 shared publications - Camilla Engblom
Department of Cell and Molecular Biology, Karolinska Institutet, Solna, Sweden
6 shared publications Hosein Toosi
KTH Royal Institute of Technology
6 shared publicationsBengt Sennblad
Artherosclerosis research unit, Department of Medicine, Karolinska Institute, Science for Life Laboratory, Stockholm, Sweden
5 shared publications
Latest Publications
- Open Access
Phylospatial optimal transport for single-cell and spatial transcriptomics data integration
The spatial organization of evolving cell populations in tumors influences how they progress and respond to treatment. Spatially resolved transcriptomics data may be used to examine the locations of these diverse cell states in tumor sections. However, these technologies often lack single-cell resolution and instead capture groups of cells in spatial spots, making it difficult to resolve cancer clones. In contrast, dissociated single-cell transcriptomics data are better suited for obtaining cell lineages, but do not capture the locations of the cells in the tissue. Here, we introduce SpOTr, an optimal transport approach that leverages the concordance between the evolutionary tree and the spatial distribution of cancer cells to integrate single-cell and spatial transcriptomics data from tumors. SpOTr combines a spot deconvolution model with Fused Gromov–Wasserstein optimal transport, in which cells that are close in the tree are drawn to nearby spots. In simulations and in real spatial lineage tracing data, SpOTr recovered the spatial locations of clones better than methods that ignore the tree. In a human colorectal liver metastasis, SpOTr mapped copy number clones from dissociated cells to spatial spots, showing that it successfully maps the evolutionary history of tumors in space.
Open AccessPhylospatial optimal transport for single-cell and spatial transcriptomics data integration
The spatial organization of evolving cell populations in tumors influences how they progress and respond to treatment. Spatially resolved transcriptomics data may be used to examine the locations of these diverse cell states in tumor sections. However, these technologies often lack single-cell resolution and instead capture groups of cells in spatial spots, making it difficult to resolve cancer clones. In contrast, dissociated single-cell transcriptomics data are better suited for obtaining cell lineages, but do not capture the locations of the cells in the tissue. Here, we introduce SpOTr, an optimal transport approach that leverages the concordance between the evolutionary tree and the spatial distribution of cancer cells to integrate single-cell and spatial transcriptomics data from tumors. SpOTr combines a spot deconvolution model with Fused Gromov–Wasserstein optimal transport, in which cells that are close in the tree are drawn to nearby spots. In simulations and in real spatial lineage tracing data, SpOTr recovered the spatial locations of clones better than methods that ignore the tree. In a human colorectal liver metastasis, SpOTr mapped copy number clones from dissociated cells to spatial spots, showing that it successfully maps the evolutionary history of tumors in space.
- Open Access
DisCell: Separating Spillover from Niche Response in Spatial Transcriptomics
Spatial transcriptomics at single-cell resolution measures every cell in its place in the tissue, but diffusion and segmentation errors also add transcripts of neighboring cells to a cell’s counts. This spillover makes a cell resemble its neighbors, and a response to the niche makes cells in the same niche resemble each other. Both tie a cell’s expression to its surroundings. The count data alone cannot tell the two apart. Findings from single-cell transcriptomes, such as a gene program that is higher in one niche than in another or signaling genes that change depending on the neighborhood, may therefore be artifacts of spillover. Current models describe a cell by its intrinsic state together with either its niche response or spillover, but none models all three. We present DisCell, the first method that models all three components jointly and measures how robust each finding is to spillover. DisCell is a generative model that describes single-cell gene expression profiles in terms of two latent variables, an intrinsic state and a response to the niche, and adds spillover from its neighbors as a separate term. DisCell fits the model at increasing levels of spillover and recomputes each finding on the spillover-free expression to see how much spillover it withstands. DisCell also estimates the most spillover a section can contain, and a finding that holds even at that amount is not explained by spillover. In simulated tissue, DisCell recovers each cell’s intrinsic state and response and tells findings created by spillover apart from genuine responses. On five sections of ovarian and lung tissue, the intrinsic state keeps more of each cell’s own properties, measured by its cell-cycle phase, than any competing method that holds as little of its neighborhood. Within each cell type, the model partitions the variation of each gene into intrinsic state, niche response and spillover. Using DisCell, we rank findings about niches by their robustness to spillover and confirm that a previously reported finding withstands spillover, that esophageal cancer cells in niches infiltrated by immune or stromal cells express more of an epithelial–mesenchymal transition program. DisCell also predicts what the gene expression of a cell type would be in another niche, with its spillover part separated, at lower error on most tasks than the competing method built for this purpose. Training the model takes under ten minutes on one consumer GPU for sections of up to 400,000 cells.
Open AccessDisCell: Separating Spillover from Niche Response in Spatial Transcriptomics
Spatial transcriptomics at single-cell resolution measures every cell in its place in the tissue, but diffusion and segmentation errors also add transcripts of neighboring cells to a cell’s counts. This spillover makes a cell resemble its neighbors, and a response to the niche makes cells in the same niche resemble each other. Both tie a cell’s expression to its surroundings. The count data alone cannot tell the two apart. Findings from single-cell transcriptomes, such as a gene program that is higher in one niche than in another or signaling genes that change depending on the neighborhood, may therefore be artifacts of spillover. Current models describe a cell by its intrinsic state together with either its niche response or spillover, but none models all three. We present DisCell, the first method that models all three components jointly and measures how robust each finding is to spillover. DisCell is a generative model that describes single-cell gene expression profiles in terms of two latent variables, an intrinsic state and a response to the niche, and adds spillover from its neighbors as a separate term. DisCell fits the model at increasing levels of spillover and recomputes each finding on the spillover-free expression to see how much spillover it withstands. DisCell also estimates the most spillover a section can contain, and a finding that holds even at that amount is not explained by spillover. In simulated tissue, DisCell recovers each cell’s intrinsic state and response and tells findings created by spillover apart from genuine responses. On five sections of ovarian and lung tissue, the intrinsic state keeps more of each cell’s own properties, measured by its cell-cycle phase, than any competing method that holds as little of its neighborhood. Within each cell type, the model partitions the variation of each gene into intrinsic state, niche response and spillover. Using DisCell, we rank findings about niches by their robustness to spillover and confirm that a previously reported finding withstands spillover, that esophageal cancer cells in niches infiltrated by immune or stromal cells express more of an epithelial–mesenchymal transition program. DisCell also predicts what the gene expression of a cell type would be in another niche, with its spillover part separated, at lower error on most tasks than the competing method built for this purpose. Training the model takes under ten minutes on one consumer GPU for sections of up to 400,000 cells.
- Open Access
- 21 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1
Author Correction: Integrative spatial and genomic analysis of tumor heterogeneity with Tumoroscope
- 21 March 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1
Open AccessAuthor Correction: Integrative spatial and genomic analysis of tumor heterogeneity with Tumoroscope
- Open Access
- 29 October 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Integrative spatial and genomic analysis of tumor heterogeneity with Tumoroscope
Spatial and genomic heterogeneity of tumors are crucial factors influencing cancer progression, treatment, and survival. However, a technology for direct mapping the clones in the tumor tissue based on somatic point mutations is lacking. Here, we propose Tumoroscope, the first probabilistic model that accurately infers cancer clones and their localization in close to single-cell resolution by integrating pathological images, whole exome sequencing, and spatial transcriptomics data. In contrast to previous methods, Tumoroscope explicitly addresses the problem of deconvoluting the proportions of clones in spatial transcriptomics spots. Applied to a reference prostate cancer dataset and a newly generated breast cancer dataset, Tumoroscope reveals spatial patterns of clone colocalization and mutual exclusion in sub-areas of the tumor tissue. We further infer clone-specific gene expression levels and the most highly expressed genes for each clone. In summary, Tumoroscope enables an integrated study of the spatial, genomic, and phenotypic organization of tumors.
- 29 October 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Open AccessIntegrative spatial and genomic analysis of tumor heterogeneity with Tumoroscope
Spatial and genomic heterogeneity of tumors are crucial factors influencing cancer progression, treatment, and survival. However, a technology for direct mapping the clones in the tumor tissue based on somatic point mutations is lacking. Here, we propose Tumoroscope, the first probabilistic model that accurately infers cancer clones and their localization in close to single-cell resolution by integrating pathological images, whole exome sequencing, and spatial transcriptomics data. In contrast to previous methods, Tumoroscope explicitly addresses the problem of deconvoluting the proportions of clones in spatial transcriptomics spots. Applied to a reference prostate cancer dataset and a newly generated breast cancer dataset, Tumoroscope reveals spatial patterns of clone colocalization and mutual exclusion in sub-areas of the tumor tissue. We further infer clone-specific gene expression levels and the most highly expressed genes for each clone. In summary, Tumoroscope enables an integrated study of the spatial, genomic, and phenotypic organization of tumors.
- Open Access
- 9 May 2024
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 20 (5) , e1012094
Scuphr: A probabilistic framework for cell lineage tree reconstruction
Cell lineage tree reconstruction methods are developed for various tasks, such as investigating the development, differentiation, and cancer progression. Single-cell sequencing technologies enable more thorough analysis with higher resolution. We present Scuphr, a distance-based cell lineage tree reconstruction method using bulk and single-cell DNA sequencing data from healthy tissues. Common challenges of single-cell DNA sequencing, such as allelic dropouts and amplification errors, are included in Scuphr. Scuphr computes the distance between cell pairs and reconstructs the lineage tree using the neighbor-joining algorithm. With its embarrassingly parallel design, Scuphr can do faster analysis than the state-of-the-art methods while obtaining better accuracy. The method’s robustness is investigated using various synthetic datasets and a biological dataset of 18 cells.
- 9 May 2024
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 20 (5) , e1012094
Open AccessScuphr: A probabilistic framework for cell lineage tree reconstruction
Cell lineage tree reconstruction methods are developed for various tasks, such as investigating the development, differentiation, and cancer progression. Single-cell sequencing technologies enable more thorough analysis with higher resolution. We present Scuphr, a distance-based cell lineage tree reconstruction method using bulk and single-cell DNA sequencing data from healthy tissues. Common challenges of single-cell DNA sequencing, such as allelic dropouts and amplification errors, are included in Scuphr. Scuphr computes the distance between cell pairs and reconstructs the lineage tree using the neighbor-joining algorithm. With its embarrassingly parallel design, Scuphr can do faster analysis than the state-of-the-art methods while obtaining better accuracy. The method’s robustness is investigated using various synthetic datasets and a biological dataset of 18 cells.
- Open Access
VICTree - a Variational Inference method for Clonal Tree reconstruction
Clonal tree inference brings crucial insights to the analysis of tumor heterogeneity and cancer evolution. Recent progress in single cell sequencing has prompted a demand for more advanced probabilistic models of copy number evolution, coupled with inference methods which can account for the noisy nature of the data along with dependencies between adjacent sites in copy number profiles. We present VICTree, a Variational Inference based algorithm for joint Bayesian inference of clonal trees, together with a novel Tree-structured Mixture Hidden Markov Model (TSMHMM) which combines HMMs related through a tree with a mixture model. For the tree inference, we introduce a new algorithm, LARS, for sampling directed labeled multifurcating trees. To evaluate our proposed method, we conduct experiments on simulated data and on samples of multiple myeloma and breast cancer. We demonstrate VICTree's capacity for reliable clustering, clonal tree reconstruction, copy number evolution and the utility of the ELBO for model selection. Lastly, VICTree's results are compared in terms of quality and speed of inference to other state-of-the art methods. The code for VICTree is available on GitHub: github.com/Lagergren-Lab/victree.
Open AccessVICTree - a Variational Inference method for Clonal Tree reconstruction
Clonal tree inference brings crucial insights to the analysis of tumor heterogeneity and cancer evolution. Recent progress in single cell sequencing has prompted a demand for more advanced probabilistic models of copy number evolution, coupled with inference methods which can account for the noisy nature of the data along with dependencies between adjacent sites in copy number profiles. We present VICTree, a Variational Inference based algorithm for joint Bayesian inference of clonal trees, together with a novel Tree-structured Mixture Hidden Markov Model (TSMHMM) which combines HMMs related through a tree with a mixture model. For the tree inference, we introduce a new algorithm, LARS, for sampling directed labeled multifurcating trees. To evaluate our proposed method, we conduct experiments on simulated data and on samples of multiple myeloma and breast cancer. We demonstrate VICTree's capacity for reliable clustering, clonal tree reconstruction, copy number evolution and the utility of the ELBO for model selection. Lastly, VICTree's results are compared in terms of quality and speed of inference to other state-of-the art methods. The code for VICTree is available on GitHub: github.com/Lagergren-Lab/victree.
- 8 December 2023
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 382 (6675) , 1137-+
Spatial transcriptomics of B cell and T cell receptors reveals lymphocyte clonal dynamics
The spatial distribution of lymphocyte clones within tissues is critical to their development, selection, and expansion. We have developed spatial transcriptomics of variable, diversity, and joining (VDJ) sequences (Spatial VDJ), a method that maps B cell and T cell receptor sequences in human tissue sections. Spatial VDJ captures lymphocyte clones that match canonical B and T cell distributions and amplifies clonal sequences confirmed by orthogonal methods. We found spatial congruency between paired receptor chains, developed a computational framework to predict receptor pairs, and linked the expansion of distinct B cell clones to different tumor-associated gene expression programs. Spatial VDJ delineates B cell clonal diversity and lineage trajectories within their anatomical niche. Thus, Spatial VDJ captures lymphocyte spatial clonal architecture across tissues, providing a platform to harness clonal sequences for therapy.
- 8 December 2023
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 382 (6675) , 1137-+
Spatial transcriptomics of B cell and T cell receptors reveals lymphocyte clonal dynamics
The spatial distribution of lymphocyte clones within tissues is critical to their development, selection, and expansion. We have developed spatial transcriptomics of variable, diversity, and joining (VDJ) sequences (Spatial VDJ), a method that maps B cell and T cell receptor sequences in human tissue sections. Spatial VDJ captures lymphocyte clones that match canonical B and T cell distributions and amplifies clonal sequences confirmed by orthogonal methods. We found spatial congruency between paired receptor chains, developed a computational framework to predict receptor pairs, and linked the expansion of distinct B cell clones to different tumor-associated gene expression programs. Spatial VDJ delineates B cell clonal diversity and lineage trajectories within their anatomical niche. Thus, Spatial VDJ captures lymphocyte spatial clonal architecture across tissues, providing a platform to harness clonal sequences for therapy.
- Open Access
Improved Variational Bayesian Phylogenetic Inference using Mixtures
We present VBPI-Mixtures, an algorithm designed to enhance the accuracy of phylogenetic posterior distributions, particularly for tree-topology and branch-length approximations. Despite the Variational Bayesian Phylogenetic Inference (VBPI), a leading-edge black-box variational inference (BBVI) framework, achieving remarkable approximations of these distributions, the multimodality of the tree-topology posterior presents a formidable challenge to sampling-based learning techniques such as BBVI. Advanced deep learning methodologies such as normalizing flows and graph neural networks have been explored to refine the branch-length posterior approximation, yet efforts to ameliorate the posterior approximation over tree topologies have been lacking. Our novel VBPI-Mixtures algorithm bridges this gap by harnessing the latest breakthroughs in mixture learning within the BBVI domain. As a result, VBPI-Mixtures is capable of capturing distributions over tree-topologies that VBPI fails to model. We deliver state-of-the-art performance on difficult density estimation tasks across numerous real phylogenetic datasets.
Open AccessImproved Variational Bayesian Phylogenetic Inference using Mixtures
We present VBPI-Mixtures, an algorithm designed to enhance the accuracy of phylogenetic posterior distributions, particularly for tree-topology and branch-length approximations. Despite the Variational Bayesian Phylogenetic Inference (VBPI), a leading-edge black-box variational inference (BBVI) framework, achieving remarkable approximations of these distributions, the multimodality of the tree-topology posterior presents a formidable challenge to sampling-based learning techniques such as BBVI. Advanced deep learning methodologies such as normalizing flows and graph neural networks have been explored to refine the branch-length posterior approximation, yet efforts to ameliorate the posterior approximation over tree topologies have been lacking. Our novel VBPI-Mixtures algorithm bridges this gap by harnessing the latest breakthroughs in mixture learning within the BBVI domain. As a result, VBPI-Mixtures is capable of capturing distributions over tree-topologies that VBPI fails to model. We deliver state-of-the-art performance on difficult density estimation tasks across numerous real phylogenetic datasets.
- Open Access
- 22 February 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics
Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer’s proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from single-cell RNA sequencing data to reconstruct high-fidelity clonal trees. We evaluate PhylEx on synthetic and well-characterized high-grade serous ovarian cancer cell line datasets. PhylEx outperforms the state-of-the-art methods both when comparing capacity for clonal tree reconstruction and for identifying clones. We analyze high-grade serous ovarian cancer and breast cancer data to show that PhylEx exploits clonal expression profiles beyond what is possible with expression-based clustering methods and clear the way for accurate inference of clonal trees and robust phylo-phenotypic analysis of cancer.
- 22 February 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Open AccessReconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics
Functional characterization of the cancer clones can shed light on the evolutionary mechanisms driving cancer’s proliferation and relapse mechanisms. Single-cell RNA sequencing data provide grounds for understanding the functional state of cancer as a whole; however, much research remains to identify and reconstruct clonal relationships toward characterizing the changes in functions of individual clones. We present PhylEx that integrates bulk genomics data with co-occurrences of mutations from single-cell RNA sequencing data to reconstruct high-fidelity clonal trees. We evaluate PhylEx on synthetic and well-characterized high-grade serous ovarian cancer cell line datasets. PhylEx outperforms the state-of-the-art methods both when comparing capacity for clonal tree reconstruction and for identifying clones. We analyze high-grade serous ovarian cancer and breast cancer data to show that PhylEx exploits clonal expression profiles beyond what is possible with expression-based clustering methods and clear the way for accurate inference of clonal trees and robust phylo-phenotypic analysis of cancer.
- Open Access
- 27 December 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (1) , S1306
Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction
Breast cancer (BC) is a complex disease comprising multiple distinct subtypes with different genetic features and pathological characteristics. Although a large number of antineoplastic compounds have been approved for clinical use, patient-to-patient variability in drug response is frequently observed, highlighting the need for efficient treatment prediction for individualized therapy. Several patient-derived models have been established lately for the prediction of drug response. However, each of these models has its limitations that impede their clinical application. Here, we report that the whole-tumor cell culture (WTC) ex vivo model could be stably established from all breast tumors with a high success rate (98 out of 116), and it could reassemble the parental tumors with the endogenous microenvironment. We observed strong clinical associations and predictive values from the investigation of a broad range of BC therapies with WTCs derived from a patient cohort. The accuracy was further supported by the correlation between WTC-based test results and patients’ clinical responses in a separate validation study, where the neoadjuvant treatment regimens of 15 BC patients were mimicked. Collectively, the WTC model allows us to accomplish personalized drug testing within 10 d, even for small-sized tumors, highlighting its potential for individualized BC therapy. Furthermore, coupled with genomic and transcriptomic analyses, WTC-based testing can also help to stratify specific patient groups for assignment into appropriate clinical trials, as well as validate potential biomarkers during drug development.
- 27 December 2022
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (1) , S1306
Open AccessBreast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction
Breast cancer (BC) is a complex disease comprising multiple distinct subtypes with different genetic features and pathological characteristics. Although a large number of antineoplastic compounds have been approved for clinical use, patient-to-patient variability in drug response is frequently observed, highlighting the need for efficient treatment prediction for individualized therapy. Several patient-derived models have been established lately for the prediction of drug response. However, each of these models has its limitations that impede their clinical application. Here, we report that the whole-tumor cell culture (WTC) ex vivo model could be stably established from all breast tumors with a high success rate (98 out of 116), and it could reassemble the parental tumors with the endogenous microenvironment. We observed strong clinical associations and predictive values from the investigation of a broad range of BC therapies with WTCs derived from a patient cohort. The accuracy was further supported by the correlation between WTC-based test results and patients’ clinical responses in a separate validation study, where the neoadjuvant treatment regimens of 15 BC patients were mimicked. Collectively, the WTC model allows us to accomplish personalized drug testing within 10 d, even for small-sized tumors, highlighting its potential for individualized BC therapy. Furthermore, coupled with genomic and transcriptomic analyses, WTC-based testing can also help to stratify specific patient groups for assignment into appropriate clinical trials, as well as validate potential biomarkers during drug development.